Verenium engages in the development and commercialization of enzymes for industrial processes.
Business Model:
Revenue: $53.4M
Employees: 51-200
Address: 100 Park Ave
City: Florham Park
State: NJ
Zip: 07932
Country: US
Verenium engages in the development and commercialization of enzymes for industrial processes.
Contact Phone:
+19732456013
Contact Email:
Listed Exchange:
NASDAQ
Ticker Symbol:
VRNM
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 12/2012 | Debt Financing | 1 | $22.5M |
Athyrium Capital Management LP Athyrium Capital Management LP |
2/2000 | IPO | $174M | 8/2008 | Venture Round | 1 | $90M |
BP BP BP |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|